Tag: LLY

  • Eli Lilly and Co Valuation – January 2019 $LLY

    Eli Lilly and Co Valuation – January 2019 $LLY

    Eli Lilly And Co does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, insufficient earnings stability or growth over the last ten years, and the high PEmg and PB ratios.

  • Eli Lilly and Co. Valuation – March 2018 $LLY

    Eli Lilly and Co. Valuation – March 2018 $LLY

    Eli Lilly And Co does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the insufficient earnings stability or growth over the last ten years, and the high PEmg and PB ratios.

  • Eli Lilly and Company Valuation – July 2016 $LLY

    Eli Lilly and Company Valuation – July 2016 $LLY

    Eli Lilly and Co does not satisfy the requirements of either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, insufficient earnings stability over the last ten years, and the high PEmg and PB ratios.

  • 47 Companies in the Spotlight This Week – 5/16/15

    47 Companies in the Spotlight This Week – 5/16/15

    We evaluated 47 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising Investors, those who are willing to do such research. We also put each company through the ModernGraham valuation model based on Benjamin Graham’s value investing formulas in order to determine an intrinsic value for each. Here’s a summary of the ModernGraham Valuations.

  • Eli Lilly & Co. Annual Valuation – 2015 $LLY

    Eli Lilly & Co. Annual Valuation – 2015 $LLY

    Eli Lilly & Co. is not suitable for either the Defensive Investor or the Enterprising Investor. The Defensive Investor is concerned with the low current ratio, insufficient earnings stability over the last ten years, and the poor PEmg and PB ratios.

  • 58 Companies in the Spotlight This Week – 1/31/15

    58 Companies in the Spotlight This Week – 1/31/15

    We evaluated 58 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising Investors, those who are willing to do such research. We also put each company through the ModernGraham valuation model based on Benjamin Graham’s value investing formulas in order to determine an intrinsic value for each. Here’s a summary of the ModernGraham Valuations.

  • Eli Lilly & Company Quarterly Valuation – January 2015 $LLY

    Eli Lilly & Company Quarterly Valuation – January 2015 $LLY

    Eli Lilly & Company is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, insufficient earnings stability over the last ten years, and the high PB ratio.

  • 18 Companies in the Spotlight This Week – 10/25/14

    18 Companies in the Spotlight This Week – 10/25/14

    We evaluated 18 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising Investors, those who are willing to do such research. We also put each company through the ModernGraham valuation model based on Benjamin Graham’s value investing formulas in order to determine an intrinsic value for each. Here’s a summary of the ModernGraham Valuations.

  • Eli Lilly & Co. Quarterly Valuation – October 2014 $LLY

    Eli Lilly & Co. Quarterly Valuation – October 2014 $LLY

    Eli Lilly qualifies for the Enterprising Investor but not the Defensive Investor due to the low current ratio, lack of earnings stability over the last ten years, and the high PB ratio.

  • 17 Companies in the Spotlight This Week – 7/19/14

    17 Companies in the Spotlight This Week – 7/19/14

    We evaluated 17 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising Investors, those who are willing to do such research. We also put each company through the ModernGraham valuation model based on Benjamin Graham’s value investing formulas in order to determine an intrinsic value for each. Here’s a summary of the ModernGraham Valuations.